Published on : Apr 07, 2016
ALBANY, New York, April 07, 2016: The research provides a holistic outlook on the global glucose monitoring devices market with Porter’s five forces analysis, which explains the bargaining power of customers, the intensity of competitive rivalry, the threat of new entrants, the threat of substitute products or services, and the bargaining power of suppliers. The researchers have also analyzed the strengths, weaknesses, opportunities, and threats impacting the market segments of the global glucose monitoring devices market. The research report aims to be a guiding document to its readers by offering them a solid framework that factors in the market drivers and restraints for making profitable business decisions.
The global glucose monitoring devices market has been growing at a high rate due to the high prevalence of diabetes amongst the overall global population. Technological advancements that are rendering simple and affordable testing methods to test blood glucose levels are also driving the global glucose monitoring devices market. According to the research report, this market is expected to rise at a CAGR of 6.52% from 2016 to 2021. The global glucose monitoring devices market will be driven by the exponential rise in the number of patients suffering from diabetes, which is the result of stressful and sedentary lifestyles. Furthermore, the rise in the disposable incomes is allowing patients to spend more on healthcare, which has also resulted in growth of the glucose monitoring devices market.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=670081
In the coming years, North America will dominate the global glucose monitoring devices market due to the presence of high disposable incomes and supportive healthcare infrastructure. Awareness of sugar-related medical conditions will also augment this market. However, analysts predict that Asia Pacific is likely to grow at a rapid pace due to the huge and increasing pool of aging people, who are far more prone to diabetes than the younger population.
Some of the key players in the global glucose monitoring devices market are Arkray, Inc., Johnson & Johnson Company, F. Hoffmann-La Roche AG, Ypsomed AG, Bayer Healthcare AG, Medtronic Inc., DexCom Inc., Novo Nordisk, Bionime Corp., Abbott Laboratories, and LifeScan. The research report profiles these companies to explain the competitive landscape of the overall glucose monitoring devices market and the regulatory framework governing it. Additionally, the research report also includes an evaluation of the research and development strategies, financial overview, investment outlook, business and marketing strategies, joint ventures, product portfolio, and strategic merger and acquisitions of these companies for the coming few years.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org